v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 28, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 11.5 $ 8.3
Restricted cash 2.3 2.4
Accounts and other receivables, net of allowances of $0.5 and $0.5, respectively 65.0 50.0
Prepayments and accrued income 5.1 5.4
Inventories 101.9 92.4
Current assets held-for-sale 0.0 5.5
Total current assets 185.8 164.0
Non-current assets    
Property, plant and equipment, net 60.0 60.2
Right-of-use assets from operating leases 7.8 8.5
Goodwill 68.8 69.6
Intangibles, net 10.5 10.9
Deferred tax assets 1.2 1.2
Pensions and other retirement benefits 54.5 54.9
Investments and loans to joint ventures and other affiliates 0.4 0.4
Total assets 389.0 369.7
Current liabilities    
Current maturities of long-term debt and short-term borrowings 0.0 25.0
Accounts payable 29.6 24.6
Accrued liabilities 28.9 27.2
Taxes on income 5.1 2.6
Current liabilities held-for-sale 0.0 2.8
Other current liabilities 16.0 16.0
Total current liabilities 79.6 98.2
Non-current liabilities    
Long-term debt 58.3 14.4
Pensions and other retirement benefits 0.1 0.1
Deferred tax liabilities 18.3 18.4
Other non-current liabilities 10.0 12.2
Total liabilities 166.3 143.3
Commitments and contingencies (Note 15)
Shareholders' equity    
Ordinary shares of £0.50 par value; authorized 40,000,000 shares for 2026 and 2025; issued 28,944,000 for 2026 and 2025; outstanding 26,759,241 and 26,640,434 for 2026 and 2025, respectively 26.5 26.5
Additional paid-in capital 228.2 228.7
Treasury shares (28.6) (27.6)
Company shares held by ESOP (0.5) (0.7)
Retained earnings 104.0 102.5
Accumulated other comprehensive loss (106.9) (103.0)
Total shareholders' equity 222.7 226.4
Total liabilities and shareholders' equity $ 389.0 $ 369.7